BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16464425)

  • 1. [Meta-analyses (QUOROM)].
    Urrutia G; Tort S; Bonfill X;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():32-7. PubMed ID: 16464425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM Statement].
    Moher D; Cook DJ; Eastwood S; Olkin I; Rennie D; Stroup DF
    Rev Esp Salud Publica; 2000; 74(2):107-18. PubMed ID: 10918802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.
    Moher D; Cook DJ; Eastwood S; Olkin I; Rennie D; Stroup DF
    Lancet; 1999 Nov; 354(9193):1896-900. PubMed ID: 10584742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized clinical trials (CONSORT)].
    Cobos-Carbó A;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():21-7. PubMed ID: 16464423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group.
    Moher D; Cook DJ; Eastwood S; Olkin I; Rennie D; Stroup DF
    Br J Surg; 2000 Nov; 87(11):1448-54. PubMed ID: 11091231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The CONSORT statement for cluster randomised trials].
    Campbell MK; Elbourne DR; Altman DG;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():28-31. PubMed ID: 16464424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement.
    Moher D; Cook DJ; Eastwood S; Olkin I; Rennie D; Stroup DF
    Onkologie; 2000 Dec; 23(6):597-602. PubMed ID: 11441269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Observational studies in epidemiology (STROBE)].
    Fernández E;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():43-8. PubMed ID: 16464427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-randomized evaluation studies (TREND)].
    Vallvé C; Artés M; Cobo E;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():38-42. PubMed ID: 16464426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Developing guidelines for reporting healthcare research: scientific rationale and procedures].
    Altman DG; Moher D
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():8-13. PubMed ID: 16464421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of the quality of reporting of meta-analyses in diagnostic research: a systematic review.
    Willis BH; Quigley M
    BMC Med Res Methodol; 2011 Dec; 11():163. PubMed ID: 22151233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transparent reporting of trials is essential.
    Altman DG
    Am J Gastroenterol; 2013 Aug; 108(8):1231-5. PubMed ID: 23912401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Checklists for authors, revisers and editors of medical journals].
    Vilardell M; Rey-Joly C
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():1-2. PubMed ID: 16464419
    [No Abstract]   [Full Text] [Related]  

  • 17. The reporting quality of meta-analyses improves: a random sampling study.
    Wen J; Ren Y; Wang L; Li Y; Liu Y; Zhou M; Liu P; Ye L; Li Y; Tian W
    J Clin Epidemiol; 2008 Aug; 61(8):770-5. PubMed ID: 18411041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    BMJ; 2009 Jul; 339():b2700. PubMed ID: 19622552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do health technology assessments comply with QUOROM diagram guidance? An empirical study.
    Hind D; Booth A
    BMC Med Res Methodol; 2007 Nov; 7():49. PubMed ID: 18021461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    PLoS Med; 2009 Jul; 6(7):e1000100. PubMed ID: 19621070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.